Search

Your search keyword '"Stebbins, Amanda"' showing total 527 results
Start Over Author "Stebbins, Amanda"
527 results on '"Stebbins, Amanda"'

4. Comparison of the effectiveness and safety of 2 aspirin doses in secondary prevention of cardiovascular outcomes in patients with chronic kidney disease: A subgroup analysis of ADAPTABLE

Author

Gupta, Kamal, Mehta, Harsh, Kim, Hwasoon, Stebbins, Amanda, Wruck, Lisa M., Muñoz, Daniel, Effron, Mark B., Anderson, R. David, Pepine, Carl J., Jain, Sandeep K., Girotra, Saket, DeWalt, Darren A., Whittle, Jeff, Benziger, Catherine P., Farrehi, Peter, Zhou, Li, Knowlton, Kirk U., Polonsky, Tamar S., Bradley, Steven M., Harrington, Robert A., Rothman, Russell L., Jones, W. Schuyler, and Hernandez, Adrian F.

Published
2023
Full Text
View/download PDF

7. Aspirin Dosing for Secondary Prevention of Atherosclerotic Cardiovascular Disease in Male and Female Patients: A Secondary Analysis of the ADAPTABLE Randomized Clinical Trial.

Author

Benziger, Catherine P., Stebbins, Amanda, Wruck, Lisa M., Effron, Mark B., Marquis-Gravel, Guillaume, Farrehi, Peter M., Girotra, Saket, Gupta, Kamal, Kripalani, Sunil, Munoz, Daniel, Polonsky, Tamar S., Sharlow, Amber, Whittle, Jeffrey, Harrington, Robert A., Rothman, Russell L., Hernandez, Adrian F., and Jones, W. Schuyler

Published
2024
Full Text
View/download PDF

8. Association of Baseline Tricuspid Regurgitation With Health Status and Clinical Outcomes After TAVR and Mitral TEER.

Author

Sammour, Yasser M., Cohen, David J., Arnold, Suzanne, Spertus, John A., Stebbins, Amanda, Vekstein, Andrew, Kosinski, Andrzej S., Goel, Sachin S., Kleiman, Neal S., Vemulapalli, Sreekanth, and Kapadia, Samir R.

Abstract

Tricuspid regurgitation (TR) is associated with worse clinical outcomes after transcatheter aortic valve replacement (TAVR) and mitral transcatheter edge-to-edge repair (M-TEER), but little is known about its association with health status outcomes. The aims of this study were to explore, using the Society of Thoracic Surgeons and American College of Cardiology TVT (Transcatheter Valve Therapy) Registry, the association between baseline TR and health status after TAVR and M-TEER and to determine if baseline TR was associated with clinical endpoints. Health status was assessed using Kansas City Cardiomyopathy Questionnaire overall summary (KCCQ-OS) score in patients enrolled in the TVT Registry who underwent isolated TAVR or M-TEER between January 2019 and June 2021. The association among baseline TR and KCCQ-OS score, being alive and well, and clinical outcomes was examined. In total, 130,097 TAVR patients (13.1% with moderate TR, 2.3% with severe TR) and 19,593 M-TEER patients (33.2% with moderate TR, 14.7% with severe TR) were included. Mean KCCQ-OS scores were lower with severe vs moderate vs none to mild TR at baseline prior to TAVR (39.4 ± 24.2 vs 45.2 ± 24.7 vs 51.3 ± 25.3; P < 0.01) or M-TEER (38.1 ± 23.9 vs 41.9 ± 24.7 vs 45.4 ± 25.2; P < 0.01) and similarly at 30 days and 1 year. The odds of being alive and well at 1 year were lower with moderate or severe TR before TAVR (adjusted OR: 0.79 [95% CI: 0.74-0.85] and adjusted OR: 0.81 [95% CI: 0.70-0.94], respectively) and severe TR before M-TEER (adjusted OR: 0.53; 95% CI: 0.40-0.71). Furthermore, moderate or severe TR before TAVR was associated with higher 1-year mortality and readmission, whereas moderate or severe TR before M-TEER was associated with higher 1-year mortality. In a large cohort of U.S. patients who underwent TAVR or M-TEER, greater baseline TR was associated with worse health status and clinical outcomes. Understanding adverse outcomes of TR in patients with coexisting valvular abnormalities is important, especially with rapidly evolving transcatheter tricuspid valve interventions. [Display omitted] [ABSTRACT FROM AUTHOR]

Published
2024
Full Text
View/download PDF

11. Abstract 14286: Comparison of Enteric Coated Aspirin With Plain Aspirin on Effectiveness and Safety in the ADAPTABLE Trial

Author

Effron, Mark B, Sleem, Amber, Stebbins, Amanda, Wruck, Lisa M, Gravel, Guillaume, Muñoz, Daniel, Re, Richard N, gupta, Kamal, Pepine, Carl, Jain, Sandeep, Girotra, Saket, Whittle, Jeffrey, Benziger, Catherine, Farrehi, Peter M, Knowlton, Kirk U, Polonsky, Tamar S, Roe, Matthew T, Rothman, Russell T, Harrington, Robert A, Jones, William S, and Hernandez, Adrian F

Published
2022
Full Text
View/download PDF

12. Abstract 14192: Effect of Aspirin Dosing in Patients Treated With P2Y12 Inhibitors for Secondary Prevention of Cardiovascular Events

Author

Girotra, Saket, Stebbins, Amanda, Wruck, Lisa M, Riley, Danielle, Kripalani, Sunil, Munoz, Daniel, Effron, Mark B, gupta, Kamal, Whittle, Jeffrey, Benziger, Catherine, Zhou, Li, Farrehi, Peter M, Polonsky, Tamar S, Ahmad, Faraz S, Roe, Matthew T, Rothman, Russell, Harrington, Robert A, Hernandez, Adrian F, and Jones, William S

Published
2022
Full Text
View/download PDF

14. Effectiveness and Safety of Enteric-Coated vs Uncoated Aspirin in Patients With Cardiovascular Disease

Author

Sleem, Amber, primary, Effron, Mark B., additional, Stebbins, Amanda, additional, Wruck, Lisa M., additional, Marquis-Gravel, Guillaume, additional, Muñoz, Daniel, additional, Re, Richard N., additional, Gupta, Kamal, additional, Pepine, Carl J., additional, Jain, Sandeep K., additional, Girotra, Saket, additional, Whittle, Jeffrey, additional, Benziger, Catherine P., additional, Farrehi, Peter M., additional, Knowlton, Kirk U., additional, Polonsky, Tamar S., additional, Roe, Matthew T., additional, Rothman, Russell L., additional, Harrington, Robert A., additional, Jones, W. Schuyler, additional, and Hernandez, Adrian F., additional

Published
2023
Full Text
View/download PDF

15. CABG Improves Outcomes in Patients With Ischemic Cardiomyopathy: 10-Year Follow-Up of the STICH Trial

Author

Howlett, Jonathan G., Stebbins, Amanda, Petrie, Mark C., Jhund, Pardeep S., Castelvecchio, Serenella, Cherniavsky, Alexander, Sueta, Carla A., Roy, Ambuj, Piña, Ileana L., Wurm, Raphael, Drazner, Mark H., Andersson, Bert, Batlle, Carmen, Senni, Michele, Chrzanowski, Lukasz, Merkely, Bela, Carson, Peter, Desvigne-Nickens, Patrice M., Lee, Kerry L., Velazquez, Eric J., and Al-Khalidi, Hussein R.

Published
2019
Full Text
View/download PDF

18. Age and Aspirin Dosing in Secondary Prevention of Atherosclerotic Cardiovascular Disease.

Author

Marquis-Gravel, Guillaume, Stebbins, Amanda, Wruck, Lisa M., Roe, Matthew T., Effron, Mark B., Hammill, Bradley G., Whittle, Jeff, VanWormer, Jeffrey J., Robertson, Holly R., Alikhaani, Jacqueline D., Kripalani, Sunil, Farrehi, Peter M., Girotra, Saket, Benziger, Catherine P., Polonsky, Tamar S., Merritt, J. Greg, Gupta, Kamal, McCormick III, Thomas E., Knowlton, Kirk U., and Jain, Sandeep K.

Published
2024
Full Text
View/download PDF

19. Aspirin Dosing for Secondary Prevention of Atherosclerotic Cardiovascular Disease in Patients Treated With P2Y12 Inhibitors

Author

Girotra, Saket, primary, Stebbins, Amanda, additional, Wruck, Lisa, additional, Marquis‐Gravel, Guillaume, additional, Gupta, Kamal, additional, Farrehi, Peter, additional, Benziger, Catherine P., additional, Effron, Mark B., additional, Whittle, Jeffrey, additional, Muñoz, Daniel, additional, Kripalani, Sunil, additional, Anderson, R. David, additional, Jain, Sandeep K., additional, Polonsky, Tamar S., additional, Ahmad, Faraz S., additional, Roe, Matthew T., additional, Rothman, Russell L., additional, Harrington, Robert A., additional, Hernandez, Adrian F., additional, and Jones, W. Schuyler, additional

Published
2023
Full Text
View/download PDF

21. TCT-111 Impact of Race and Sex on Outcomes of Transcatheter Mitral Valve Repair: Insights From the Society of Thoracic Surgeons/American College of Cardiology Transcatheter Valve Therapies Registry

Author

Park, Kyeeun, primary, Aung, Pyi Phyo, additional, Wu, Fangcheng, additional, Xi, Qian Lan, additional, Khanal, Kishor, additional, Stebbins, Amanda, additional, Khalili, Houman, additional, Vekstein, Andrew, additional, and Vemulapalli, Sreekanth, additional

Published
2023
Full Text
View/download PDF

22. Comparative Effectiveness of Aspirin Dosing in Cardiovascular Disease and Diabetes Mellitus: A Subgroup Analysis of the ADAPTABLE Trial

Author

Narcisse, Dennis I, primary, Kim, Hwasoon, primary, M. Wruck, Lisa, primary, L. Stebbins, Amanda, primary, Muñoz, Daniel, primary, Kripalani, Sunil, primary, Effron, Mark B., primary, Gupta, Kamal, primary, Anderson, R. David, primary, Jain, Sandeep K., primary, Girotra, Saket, primary, Whittle, Jeff, primary, Benziger, Catherine P., primary, Farrehi, Peter, primary, Zhou, Li, primary, Polonsky, Tamar S, primary, Ahmad, Faraz S., primary, Roe, Matthew T., primary, Rothman, Russell L., primary, Harrington, Robert A., primary, Hernandez, Adrian F, primary, and Jones, W. Schuyler, primary

Published
2023
Full Text
View/download PDF

23. Comparative Effectiveness of Aspirin Dosing in Cardiovascular Disease and Diabetes Mellitus: A Subgroup Analysis of the ADAPTABLE Trial

Author

Narcisse, Dennis I., primary, Kim, Hwasoon, additional, Wruck, Lisa M., additional, Stebbins, Amanda L., additional, Muñoz, Daniel, additional, Kripalani, Sunil, additional, Effron, Mark B., additional, Gupta, Kamal, additional, Anderson, R. David, additional, Jain, Sandeep K., additional, Girotra, Saket, additional, Whittle, Jeff, additional, Benziger, Catherine P., additional, Farrehi, Peter, additional, Zhou, Li, additional, Polonsky, Tamar S., additional, Ahmad, Faraz S., additional, Roe, Matthew T., additional, Rothman, Russell L., additional, Harrington, Robert A., additional, Hernandez, Adrian F., additional, and Jones, W. Schuyler, additional

Published
2023
Full Text
View/download PDF

25. Prevalent digoxin use and subsequent risk of death or hospitalization in ambulatory heart failure patients with a reduced ejection fraction—Findings from the Heart Failure: A Controlled Trial Investigating Outcomes of Exercise Training (HF-ACTION) randomized controlled trial

Author

Ambrosy, Andrew P., Bhatt, Ankeet S., Stebbins, Amanda L., Wruck, Lisa M., Fudim, Marat, Greene, Stephen J., Kraus, William E., O'Connor, Christopher M., Piña, Ileana L., Whellan, David J., and Mentz, Robert J.

Published
2018
Full Text
View/download PDF

26. Inclusion of Functional Status Measures in the Risk Adjustment of 30-Day Mortality After Transcatheter Aortic Valve Replacement: A Report From the Society of Thoracic Surgeons/American College of Cardiology TVT Registry

Author

Arnold, Suzanne V., O’Brien, Sean M., Vemulapalli, Sreekanth, Cohen, David J., Stebbins, Amanda, Brennan, J. Matthew, Shahian, David M., Grover, Fred L., Holmes, David R., Thourani, Vinod H., Peterson, Eric D., and Edwards, Fred H.

Published
2018
Full Text
View/download PDF

27. Predictors of early dyspnoea relief in acute heart failure and the association with 30‐day outcomes: findings from ASCEND‐HF

Author

Mentz, Robert J, Hernandez, Adrian F, Stebbins, Amanda, Ezekowitz, Justin A, Felker, G Michael, Heizer, Gretchen M, Atar, Dan, Teerlink, John R, Califf, Robert M, Massie, Barry M, Hasselblad, Vic, Starling, Randall C, O'Connor, Christopher M, and Ponikowski, Piotr

Subjects
Biomedical and Clinical Sciences, Clinical Sciences, Clinical Research, Cardiovascular, Clinical Trials and Supportive Activities, Aging, Good Health and Well Being, Acute Disease, Age Factors, Aged, Blood Pressure, Blood Urea Nitrogen, Dyspnea, Edema, Female, Heart Failure, Hospitalization, Humans, Male, Middle Aged, Natriuretic Agents, Natriuretic Peptide, Brain, Natriuretic Peptides, Respiratory Rate, Risk Assessment, Treatment Outcome, Acute heart failure, Dyspnoea relief, Prognosis, Outcomes, Cardiorespiratory Medicine and Haematology, Cardiovascular System & Hematology, Cardiovascular medicine and haematology
Abstract

AimsTo examine the characteristics associated with early dyspnoea relief during acute heart failure (HF) hospitalization, and its association with 30-day outcomes.Methods and resultsASCEND-HF was a randomized trial of nesiritide vs. placebo in 7141 patients hospitalized with acute HF in which dyspnoea relief at 6 h was measured on a 7-point Likert scale. Patients were classified as having early dyspnoea relief if they experienced moderate or marked dyspnoea improvement at 6 h. We analysed the clinical characteristics, geographical variation, and outcomes (mortality, mortality/HF hospitalization, and mortality/hospitalization at 30 days) associated with early dyspnoea relief. Early dyspnoea relief occurred in 2984 patients (43%). In multivariable analyses, predictors of dyspnoea relief included older age and oedema on chest radiograph; higher systolic blood pressure, respiratory rate, and natriuretic peptide level; and lower serum blood urea nitrogen (BUN), sodium, and haemoglobin (model mean C index = 0.590). Dyspnoea relief varied markedly across countries, with patients enrolled from Central Europe having the lowest risk-adjusted likelihood of improvement. Early dyspnoea relief was associated with lower risk-adjusted 30-day mortality/HF hospitalization [hazard ratio (HR) 0.81; 95% confidence interval (CI) 0.68-0.96] and mortality/hospitalization (HR 0.85; 95% CI 0.74-0.99), but similar mortality.ConclusionClinical characteristics such as respiratory rate, pulmonary oedema, renal function, and natriuretic peptide levels are associated with early dyspnoea relief, and moderate or marked improvement in dyspnoea was associated with a lower risk for 30-day outcomes.

Published
2013

28. Transcatheter Mitral Valve Repair for Degenerative Mitral Regurgitation

Author

Makkar, Raj R., primary, Chikwe, Joanna, additional, Chakravarty, Tarun, additional, Chen, Qiudong, additional, O’Gara, Patrick T., additional, Gillinov, Marc, additional, Mack, Michael J., additional, Vekstein, Andrew, additional, Patel, Dhairya, additional, Stebbins, Amanda Lee, additional, Gelijns, Annetine C., additional, Makar, Moody, additional, Bhatt, Deepak L., additional, Kapadia, Samir, additional, Vemulapalli, Sreekanth, additional, and Leon, Martin B., additional

Published
2023
Full Text
View/download PDF

29. B-55 | Impact of Baseline Tricuspid Regurgitation on Health Status and Clinical Outcomes After Transcatheter Aortic Valve Replacement: Insights from the STS/ACC TVT Registry

Author

Sammour, Yasser, primary, Cohen, David J., additional, Arnold, Suzanne V., additional, Spertus, John A., additional, Stebbins, Amanda, additional, Vekstein, Andrew, additional, Kosinski, Andrzej, additional, Goel, Sachin S., additional, Kleiman, Neal S., additional, Vemulapalli, Sreekanth, additional, and Kapadia, Samir Ramesh, additional

Published
2023
Full Text
View/download PDF

30. D-45 | Impact of Baseline Tricuspid Regurgitation on Health Status and Clinical Outcomes After Transcatheter Edge-to-Edge Repair of the Mitral Valve: Insights from the STS/ACC TVT Registry

Author

Sammour, Yasser, primary, Cohen, David J., additional, Arnold, Suzanne V., additional, Spertus, John A., additional, Stebbins, Amanda, additional, Vekstein, Andrew, additional, Kosinski, Andrzej, additional, Goel, Sachin S., additional, Kleiman, Neal S., additional, Vemulapalli, Sreekanth, additional, and Kapadia, Samir Ramesh, additional

Published
2023
Full Text
View/download PDF

32. Comparative Effectiveness of Aspirin Dosing in Cardiovascular Disease and Diabetes Mellitus: A Subgroup Analysis of the ADAPTABLE Trial.

Author

Narcisse, Dennis I., Kim, Hwasoon, Wruck, Lisa M., Stebbins, Amanda L., Muñoz, Daniel, Kripalani, Sunil, Effron, Mark B., Gupta, Kamal, Anderson, R. David, Jain, Sandeep K., Girotra, Saket, Whittle, Jeff, Benziger, Catherine P., Farrehi, Peter, Zhou, Li, Polonsky, Tamar S., Ahmad, Faraz S., Roe, Matthew T., Rothman, Russell L., and Harrington, Robert A.

Abstract

OBJECTIVE: Patients with diabetes mellitus (DM) and concomitant atherosclerotic cardiovascular disease (ASCVD) must be on the most effective dose of aspirin to mitigate risk of future adverse cardiovascular events. RESEARCH DESIGN AND METHODS: ADAPTABLE, an open-label, pragmatic study, randomized patients with stable, chronic ASCVD to 81 mg or 325 mg of daily aspirin. The effects of aspirin dosing was assessed on the primary effectiveness outcome, a composite of all-cause death, hospitalization for myocardial infarction, or hospitalization for stroke, and the primary safety outcome of hospitalization for major bleeding. In this prespecified analysis, we used Cox proportional hazards models to compare aspirin dosing in patients with and without DM for the primary effectiveness and safety outcome. RESULTS: Of 15,076 patients, 5,676 (39%) had DM of whom 2,820 (49.7%) were assigned to 81 mg aspirin and 2,856 (50.3%) to 325 mg aspirin. Patients with versus without DM had higher rates of the composite cardiovascular outcome (9.6% vs. 5.9%; P < 0.001) and bleeding events (0.78% vs. 0.50%; P < 0.001). When comparing 81 mg vs. 325 mg of aspirin, patients with DM had no difference in the primary effectiveness outcome (9.3% vs. 10.0%; hazard ratio [HR] 0.98 [95% CI 0.83–1.16]; P = 0.265) or safety outcome (0.87% vs. 0.69%; subdistribution HR 1.25 [95% CI 0.72–2.16]; P = 0.772). CONCLUSIONS: This study confirms the inherently higher risk of patients with DM irrespective of aspirin dosing. Our findings suggest that a higher dose of aspirin yields no added clinical benefit, even in a more vulnerable population. [ABSTRACT FROM AUTHOR]

Published
2024
Full Text
View/download PDF

34. Outcomes among patients with peripheral artery disease in the Aspirin Dosing: A Patient-Centric Trial Assessing Benefits and Long-Term Effectiveness (ADAPTABLE) study

Author

Weissler, E Hope, primary, Stebbins, Amanda, additional, Wruck, Lisa, additional, Muñoz, Daniel, additional, Gupta, Kamal, additional, Girotra, Saket, additional, Whittle, Jeff, additional, Benziger, Catherine P, additional, Polonsky, Tamar S, additional, Bradley, Steven M, additional, Hammill, Bradley G, additional, Merritt, James G, additional, Zemon, Doris N, additional, Hernandez, Adrian F, additional, and Jones, W Schuyler, additional

Published
2023
Full Text
View/download PDF

37. sj-pdf-1-vmj-10.1177_1358863X231154951 – Supplemental material for Outcomes among patients with peripheral artery disease in the Aspirin Dosing: A Patient-Centric Trial Assessing Benefits and Long-Term Effectiveness (ADAPTABLE) study

Author

Weissler, E Hope, Stebbins, Amanda, Wruck, Lisa, Muñoz, Daniel, Gupta, Kamal, Girotra, Saket, Whittle, Jeff, Benziger, Catherine P, Polonsky, Tamar S, Bradley, Steven M, Hammill, Bradley G, Merritt, James G, Zemon, Doris N, Hernandez, Adrian F, and Jones, W Schuyler

Subjects
FOS: Clinical medicine, Cardiology, 110323 Surgery
Abstract

Supplemental material, sj-pdf-1-vmj-10.1177_1358863X231154951 for Outcomes among patients with peripheral artery disease in the Aspirin Dosing: A Patient-Centric Trial Assessing Benefits and Long-Term Effectiveness (ADAPTABLE) study by E Hope Weissler, Amanda Stebbins, Lisa Wruck, Daniel Muñoz, Kamal Gupta, Saket Girotra, Jeff Whittle, Catherine P Benziger, Tamar S Polonsky, Steven M Bradley, Bradley G Hammill, James G Merritt, Doris N Zemon, Adrian F Hernandez and W Schuyler Jones in Vascular Medicine

Published
2023
Full Text
View/download PDF

38. Association Between Peripheral Versus Central Access for Alternative Access Transcatheter Aortic Valve Replacement and Mortality and Stroke: A Report From the Society of Thoracic Surgeons/American College of Cardiology Transcatheter Valve Therapy Registry

Author

Kaneko, Tsuyoshi, primary, Hirji, Sameer A., additional, Yazdchi, Farhang, additional, Sun, Yee-Ping, additional, Nyman, Charles, additional, Shook, Douglas, additional, Cohen, David J., additional, Stebbins, Amanda, additional, Zeitouni, Michel, additional, Vemulapalli, Sreekanth, additional, Thourani, Vinod H., additional, Shah, Pinak B., additional, and O’Gara, Patrick, additional

Published
2022
Full Text
View/download PDF

39. Conscious Sedation Versus General Anesthesia for Transcatheter Aortic Valve Replacement: Insights from the National Cardiovascular Data Registry Society of Thoracic Surgeons/American College of Cardiology Transcatheter Valve Therapy Registry

Author

Hyman, Matthew C., Vemulapalli, Sreekanth, Szeto, Wilson Y., Stebbins, Amanda, Patel, Prakash A., Matsouaka, Roland A., Herrmann, Howard C., Anwaruddin, Saif, Kobayashi, Taisei, Desai, Nimesh D., Vallabhajosyula, Prashanth, McCarthy, Fenton H., Li, Robert, Bavaria, Joseph E., and Giri, Jay

Published
2017
Full Text
View/download PDF

44. Practice Patterns and Outcomes of Transcatheter Aortic Valve Replacement in the United States and Japan: A Report From Joint Data Harmonization Initiative of STS/ACC TVT and J‐TVT

Author

Kaneko, Tsuyoshi, primary, Vemulapalli, Sreekanth, additional, Kohsaka, Shun, additional, Shimamura, Kazuo, additional, Stebbins, Amanda, additional, Kumamaru, Hiraku, additional, Nelson, Adam J., additional, Kosinski, Andrzej, additional, Maeda, Koichi, additional, Bavaria, Joseph E., additional, Saito, Shigeru, additional, Reardon, Michael J., additional, Kuratani, Toru, additional, Popma, Jeffrey J., additional, Inohara, Taku, additional, Thourani, Vinod H., additional, Carroll, John D., additional, Shimizu, Hideyuki, additional, Takayama, Morimasa, additional, Leon, Martin B., additional, Mack, Michael J., additional, and Sawa, Yoshiki, additional

Published
2022
Full Text
View/download PDF

45. SEX DIFFERENCES IN EFFECTIVENESS AND SAFETY OF ASPIRIN IN SECONDARY PREVENTION OF CARDIOVASCULAR OUTCOMES IN PATIENTS: A SUBGROUP ANALYSIS FROM THE ADAPTABLE STUDY

Author

Benziger, Catherine P., primary, Stebbins, Amanda, additional, Lisa, Wruck, additional, Marquis-Gravel, Guillaume, additional, Ahmad, Faraz S., additional, Farrehi, Peter M., additional, Girotra, Saket, additional, Gupta, Kamal, additional, Kripalani, Sunil, additional, Mehta, Harsh, additional, Munoz, Daniel, additional, Polonsky, Tamar, additional, Sharlow, Amber, additional, Whittle, Jeffrey, additional, Hernandez, Adrian F., additional, and Jones, W. Schuyler, additional

Published
2022
Full Text
View/download PDF

47. Renal function and coronary bypass surgery in patients with ischemic heart failure

Author

Doenst, Torsten, primary, Haddad, Haissam, additional, Stebbins, Amanda, additional, Hill, James A., additional, Velazquez, Eric J., additional, Lee, Kerry L., additional, Rouleau, Jean L., additional, Sopko, George, additional, Farsky, Pedro S., additional, Al-Khalidi, Hussein R., additional, Jeemon, Panniyammakal, additional, Szwed, Hanna, additional, Tan, Ru-San, additional, Bigalli, Daniel R., additional, Kosevic, Dragana, additional, Benke, Kalman, additional, Kalil, Renato A.K., additional, Jasinski, Marek, additional, Smith, Peter K., additional, and Chua, Yeow Leng, additional

Published
2022
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results